|
Doxil Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Liposomal doxorubicin, doxorubicin hydrochloride liposome injection
Louisville, Kentucky1 trial
Combination Therapy for Recurrent Ovarian Cancer
UofL Health Brown Cancer Center
Phase 1/2
Columbia, Maryland1 trial
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Maryland Oncology Hematology
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.